IDO1 and breast cancer: As recently reported, breast cancer (BC)-derived L-EVs can contain large amounts of indoleamine-2,3-dioxygenase (IDO) [52], an enzyme that is involved in tryptophan metabolism and plays a pivotal role in the establishment of an immune-suppressed microenvironment by dampening the T-cell proliferation [53].